PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with 64Cu, 68Ga, and 111In

Molecular Pharmaceutics

Volumn 11, Issue 11, 2014, Pages 3930-3937

  Roosenburg, S ^a   Laverman, P ^a   Joosten, L ^a   Cooper, M S ^c   Kolenc Peitl, P K ^d   Foster, J M ^b   Hudson, C ^b   Leyton, J ^b   Burnet, J ^b   Oyen, W J G ^a   Blower, P J ^c   Mather, S J ^b   Boerman, O C ^a   Sosabowski, J K ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

CCK2R peptide; Cu 64; DOTA; Ga 68; In 111; Macrocyclic chelator; NODAGA; NOTA; PET imaging

Indexed keywords

1 (1,3 CARBOXYPROPYL) 4,7 CARBOXYMETHYL 1,4,7T RIAZACYCLONONANE; 1,4,7 TRIAZACYCLONONANE N,N',N'' TRIACETIC ACID; CHELATING AGENT; CHOLECYSTOKININ B RECEPTOR; COPPER 64; GALLIUM 68; GASTRIN DERIVATIVE; INDIUM 111; MINIGASTRIN; TETRAXETAN; UNCLASSIFIED DRUG; 1,4,7,10-TETRAAZACYCLODODECANE- 1,4,7,10-TETRAACETIC ACID; 1,4,7-TRIAZACYCLONONANE-N,N',N''-TRIACETIC ACID; 1-(1,3-CARBOXYPROPYL)-4,7-CARBOXYMETHYL-1,4,7-TRIAZACYCLONONANE; ACETIC ACID DERIVATIVE; COPPER; GALLIUM; GASTRIN; HETEROCYCLIC COMPOUND; INDIUM; PEPTIDE; RADIOPHARMACEUTICAL AGENT; SINGLE HETEROCYCLIC RINGS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG UPTAKE; DUODENUM; EX VIVO STUDY; FEMALE; IC50; ISOTOPE LABELING; KIDNEY; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR VOLUME; ANIMAL; CANCER TRANSPLANTATION; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; METABOLISM; MULTIMODAL IMAGING; SCID MOUSE; TUMOR CELL LINE;

ACETATES; ANIMALS; CELL LINE, TUMOR; CHELATING AGENTS; COPPER RADIOISOTOPES; FEMALE; GALLIUM RADIOISOTOPES; GASTRINS; HETEROCYCLIC COMPOUNDS; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; INDIUM RADIOISOTOPES; INHIBITORY CONCENTRATION 50; MICE; MICE, SCID; MULTIMODAL IMAGING; NEOPLASM TRANSPLANTATION; PEPTIDES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTOR, CHOLECYSTOKININ B; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84933546506     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp500283k     Document Type: Article

References (26)

1. Reubi, J.-C.; Schaer, J.-C.; Waser, B. Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors. Cancer Res. 1997, 57, 1377-1386
2. Laverman, P.; Joosten, L.; Eek, A.; Roosenburg, S.; Kolenc Peitl, P.; Maina, T.; Maecke, H.; Aloj, L.; von Guggenberg, E.; Sosabowski, J. K.; de Jong, M.; Reubi, J.-C.; Oyen, W. J. G.; Boerman, O. C. Comparative biodistribution of 12 111In-labelled gastrin/CCK2 receptor-targeting peptides. Eur. J. Nucl. Med. Mol. Imaging 2011, 38, 1410-1416
3. Aloj, L.; Aurilio, M.; Rinaldi, V.; D'Ambrosio, L.; Tesauro, D.; Peitl, P. K.; Maina, T.; Mansi, R.; Von Guggenberg, E.; Joosten, L.; Sosabowski, J. K.; Breeman, W. A. P.; De Blois, E.; Koelewijn, S.; Melis, M.; Waser, B.; Beetschen, K.; Reubi, J. C.; De Jong, M. Comparison of the binding and internalization properties of 12 DOTA-coupled and 111In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607. Eur. J. Nucl. Med. Mol. Imaging 2011, 38, 1417-1425
4. Ocak, M.; Helbok, A.; Rangger, C.; Peitl, P. K.; Nock, B. A.; Morelli, G.; Eek, A.; Sosabowski, J. K.; Breeman, W. A. P.; Reubi, J. C.; Decristoforo, C. Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607. Eur. J. Nucl. Med. Mol. Imaging 2011, 38, 1426-1435
5. Behr, T. M.; Jenner, N.; Behe, M. P.; Angerstein, C.; Gratz, S.; Raue, F.; Becker, W. Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors. J. Nucl. Med. 1999, 40, 1029-1044
6. Good, S.; Walter, M. A.; Waser, B.; Wang, X.; Müller-Brand, J.; Behe, M. P.; Reubi, J.-C.; Maecke, H. R. Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptorexpressing tumours. Eur. J. Nucl. Med. Mol. Imaging 2008, 35, 1868-1877
7. Behe, M. P.; Kluge, G.; Becker, W.; Gotthardt, M.; Behr, T. M. Use of polyglutamic acids to reduce uptake of radiometal-labeled minigastrin in the kidneys. J. Nucl. Med. 2005, 46, 1012-1015
8. Nock, B. A.; Maina, T.; Behe, M. P.; Nikolopoulou, A.; Gotthardt, M.; Schmitt, J. S.; Behr, T. M.; Maecke, H. R. CCK-2/gastrin receptortargeted tumor imaging with 99mTc-labeled minigastrin analogs. J. Nucl. Med. 2005, 46, 1727-1736
9. Kolenc Peitl, P.; Mansi, R.; Tamma, M.; Gmeiner-Stopar, T.; Sollner-Dolen, M.; Waser, B.; Baum, R. P.; JC, R.; Maecke, H. Highly Improved Metabolic Stability and Pharmacokinetics of Indium-111-DOTA-Gastrin Conjugates for Targeting of the Gastrin Receptor. J. Med. Chem. 2011, 54, 2602-2609
10. Cooper, M. S.; Ma, M. T.; Sunassee, K.; Shaw, K. P.; Williams, J. D.; Paul, R. L.; Donnelly, P. S.; Blower, P. J. Comparison of 64Cu-Complexing Bifunctional Chelators for Radioimmunoconjugation: Labeling Efficiency, Specific Activity, and in Vitro/in Vivo Stability. Bioconjugate Chem. 2012, 23, 1029-1039
11. Brom, M.; Joosten, L.; Oyen, W. J. G.; Gotthardt, M.; Boerman, O. C. Improved labelling of DTPA-and DOTA-conjugated peptides and antibodies with 111In in HEPES and MES buffer. Eur. J. Nucl. Med. Mol. Imaging Res. 2012, 2, 4
12. Aloj, L.; Caraco, C.; Panico, M.; Zannetti, A.; Del Vecchio, S.; Tesauro, D.; De Luca, S.; Arra, C.; Pedone, C.; Morelli, G.; Salvatore, M. In vitro and in vivo evaluation of 111In-DTPAGlu-G-CCK8 for cholecystokinin-B receptor imaging. J. Nucl. Med. 2004, 45, 485-494
13. Laverman, P.; McBride, W. J.; Sharkey, R. M.; Eek, A.; Joosten, L.; Oyen, W. J.; Goldenberg, D. M.; Boerman, O. C. A novel facile method of labeling octreotide with 18F-fluorine. J. Nucl. Med. 2010, 51 (3), 454-461
14. Ma, M. T.; Cooper, M. S.; Paul, R. L.; Shaw, K. P.; Karas, J. A.; Scanlon, D.; White, J. M.; Blower, P. J.; Donnelly, P. S. Macrobicyclic cage amine ligands for copper radiopharmaceuticals: a single bivalent cage amine containing two Lys3-bombesin targeting peptides. Inorg. Chem. 2011, 50 (14), 6701-6710
15. Aloj, L.; Aurilio, M.; Rinaldi, V.; D'Ambrosio, L.; Tesauro, D.; Peitl, P. K.; Maina, T.; Mansi, R.; von Guggenberg, E.; Joosten, L.; Sosabowski, J. K.; Breeman, W. A.; De Blois, E.; Koelewijn, S.; Melis, M.; Waser, B.; Beetschen, K.; Reubi, J. C.; de Jong, M. Comparison of the binding and internalization properties of 12 DOTA-coupled and 111In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607. Eur. J. Nucl. Med. Mol. Imaging 2011, 38 (8), 1417-1425
16. Laverman, P.; Joosten, L.; Eek, A.; Roosenburg, S.; Peitl, P. K.; Maina, T.; Macke, H.; Aloj, L.; von Guggenberg, E.; Sosabowski, J. K.; de Jong, M.; Reubi, J. C.; Oyen, W. J.; Boerman, O. C. Comparative biodistribution of 12 In-111-labelled gastrin/CCK2 receptor-targeting peptides. Eur. J. Nucl. Med. Mol. Imaging 2011, 38 (8), 1410-1416
17. Bass, L. A.; Wang, M.; Welch, M. J.; Anderson, C. J. In Vivo Transchelation of Copper-64 from TETA-Octreotide to Superoxide Dismutase in Rat Liver. Bioconjugate Chem. 2000, 11, 527-532
18. Anderson, C. J.; Wadas, T. J.; Wong, E. H.; Weisman, G. R. Cross-bridged macrocyclic chelators for stable complexation of copper radionuclides for PET imaging. Q. Nucl. Med. Mol. Imaging 2008, 52, 185-192
19. 19) Prasanphanich, A. F.; Nanda, P. K.; Rold, T. L.; Ma, L.; Lewis, M. R.; Garrison, J. C.; Hoffman, T. J.; Sieckman, G. L.; Figueroa, S. D.; Smith, C. J. [64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrinreleasing peptide receptor-expressing tissues. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 12462-12467
20. Wadas, T. J.; Wong, E. H.; Weisman, G. R.; Anderson, C. J. Copper chelation chemistry and its role in copper radiopharmaceuticals. Curr. Pharm. Des. 2007, 13, 3-16
21. Dumont, R. A.; Deininger, F.; Haubner, R.; Maecke, H. R.; Weber, W. A.; Fani, M. Novel 64Cu-and 68Ga-Labeled RGD conjugates show improved PET imaging of αvß3 integrin expression and facile radiosynthesis. J. Nucl. Med. 2011, 52, 1276-1284
22. Fani, M.; Del Pozzo, L.; Abiraj, K.; Mansi, R.; Tamma, M. L.; Cescato, R.; Waser, B.; Weber, W. A.; Reubi, J. C.; Maecke, H. R. PET of somatostatin receptor-positive tumors using 64Cu-and 68Gasomatostatin antagonists: the chelate makes the difference. J. Nucl. Med. 2011, 52 (7), 1110-1118
23. Malmberg, J.; Perols, A.; Varasteh, Z.; Altai, M.; Braun, A.; Sandström, M.; Garske, U.; Tolmachev, V.; Orlova, A.; Karlström, A. Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts. Eur. J. Nucl. Med. Mol. Imaging 2012, 39, 481-492
24. Eisenwiener, K.; Prata, M. I.; Buschmann, I.; Zhang, H. W.; Santos, A. C.; Wenger, S.; Reubi, J. C.; HR, M. NODAGATOC, a new chelator-coupled somatostatin analogue labeled with [67/68Ga] and [111In] for SPECT, PET, and targeted therapeutic applications of somatostatin receptor (hsst2) expressing tumors. Bioconjugate Chem. 2002, 13, 530-541
25. Knetsch, P. A.; Petrik, M.; Griessinger, C. M.; Rangger, C.; Fani, M.; Kesenheimer, C.; Von Guggenberg, E.; Pichler, B. J.; Virgolini, I.; Decristoforo, C.; Haubner, R. [68Ga]NODAGA-RGD for imaging αvß3 integrin expression. Eur. J. Nucl. Med. Mol. Imaging 2011, 38, 1303-1312
26. Hu, L. Y.; Bauer, N.; Knight, L. M.; Li, Z.; Liu, S.; Anderson, C. J.; Conti, P. S.; Sutcliffe, J. L. Characterization and Evaluation of 64Cu-Labeled A20FMDV2 Conjugates for Imaging the Integrin αvß6. Mol. Imaging Biol. 2014, Doi: 10.1007/s11307-013-0717-9.